4

2 comments

[–] Justintoxicated 1 points (+1|-0)

In a statement released Thursday afternoon, the companies said they have seen "encouraging data" from an ongoing trial of the booster shot, adding that it provides levels of neutralizing antibodies five to 10 times higher, when administered six months after the second dose. The companies plan to submit data "in the coming weeks."

First they should have to prove that reinfection after 2 doses is a common occurrence and at what point from the second dose do the antibodies lose effectiveness against the disease... Like any other vaccine.

[–] jobes [OP] 1 points (+1|-0) Edited

Why let pesky "science" stand in the way of pharma company profits?

Also, until that "authorized under emergency use" declaration goes away, we won't see any sort of studies like that. Pfizer and Moderna's FDA filings for the original jabs explicitly said "we don't know if it will prevent infection" and "we don't know how long it will be effective" and here we are with hundreds of millions of people injected with it already.